Jazz Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.

About JAZZ

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. 

CEO
Renée D. Galá
CEORenée D. Galá
Employees
2,800
Employees2,800
Headquarters
Dublin, Dublin
HeadquartersDublin, Dublin
Founded
2005
Founded2005
Employees
2,800
Employees2,800

JAZZ Key Statistics

Market cap
10.25B
Market cap10.25B
Price-Earnings ratio
-27.79
Price-Earnings ratio-27.79
Dividend yield
Dividend yield
Average volume
1.13M
Average volume1.13M
High today
$171.51
High today$171.51
Low today
$167.00
Low today$167.00
Open price
$170.56
Open price$170.56
Volume
1.07M
Volume1.07M
52 Week high
$182.99
52 Week high$182.99
52 Week low
$95.49
52 Week low$95.49

Stock Snapshot

The current Jazz Pharmaceuticals(JAZZ) stock price is $168.71, with a market capitalization of 10.25B. The stock trades at a price-to-earnings (P/E) ratio of -27.79.

As of 2026-01-24, Jazz Pharmaceuticals(JAZZ) stock has fluctuated between $167.00 and $171.51. The current price stands at $168.71, placing the stock +1.0% above today's low and -1.6% off the high.

The Jazz Pharmaceuticals(JAZZ)'s current trading volume is 1.07M, compared to an average daily volume of 1.13M.

In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $182.99 and a 52-week low of $95.49.

In the last year, Jazz Pharmaceuticals(JAZZ) shares hit a 52-week high of $182.99 and a 52-week low of $95.49.

JAZZ News

Simply Wall St 1d
Assessing Jazz Pharmaceuticals Valuation After New Boehringer Ingelheim Oncology Collaboration

Advertisement Why Jazz Pharmaceuticals is back on investors’ radar Boehringer Ingelheim’s new clinical collaboration with Jazz Pharmaceuticals (JAZZ), pairing...

Assessing Jazz Pharmaceuticals Valuation After New Boehringer Ingelheim Oncology Collaboration

Analyst ratings

94%

of 18 ratings
Buy
94.4%
Hold
5.6%
Sell
0%

People also own

Based on the portfolios of people who own JAZZ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.